Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HPV Genotyping from the high risk mRNA Aptima assay- a direct approach using DNA from Aptima sample tubes.

Journal of virological methods - 1 Sept 2016

Lillsunde Larsson G, Kaliff M, Bergengren L, Karlsson M G, Helenius G

Abstract excerpt

The underlying cause of cervical cancer is an infection with the human papilloma virus (HPV) and HPV testing can be used for cervical cancer screening. The Aptima HPV assay from Hologic is an mRNA HPV test used to identify clinically relevant infections but the method does not discriminate between the different high risk genotypes. The aim of the current study was to evaluate if analyzed Aptima sample transfer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Human Papillomavirus DNA Tests

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Diagnostic Techniques

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Sensitivity and Specificity

Share to Uterine Cervical Dysplasia

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 27233487
DOI: 10.1016/j.jviromet.2016.05.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HPV Genotyping from the high risk mRNA Aptima assay- a direct approach using DNA from Aptima sample tubes.PMID 27233487Read ↗

A review of the clinical performance of the Aptima HPV assay.Semantic proximity Read ↗

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.Semantic proximity Read ↗

APTIMA mRNA vs. DNA-Based HPV Assays: Analytical Performance Insights from a Resource-Limited South African Setting.Semantic proximity Read ↗

Performance of the HPV E6/E7 mRNA Aptima HPV assay combined with partial genotyping compared with the HPV DNA Cobas 4800 HPV test for use in primary screening: Results from the CERVIVA HPV primary screening study in Ireland.Semantic proximity Read ↗

Aptima HPV E6/E7 mRNA Test Is as Sensitive as Hybrid Capture 2 Assay but More Specific at Detecting Cervical Precancer and CancerSemantic proximity Read ↗

Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers.Semantic proximity Read ↗

Superior Analytical Specificity of APTIMA mRNA HPV Testing over DNA Assays in a Resource-Limited South African SettingSemantic proximity Read ↗

Impact of nucleic acid extraction procedures on human papillomavirus (HPV) detection and genotyping.Semantic proximity Read ↗

Comparison of the clinical performance of an HPV mRNA test and an HPV DNA test in triage of atypical squamous cells of undetermined significance (ASC‐US)Semantic proximity Read ↗

Evaluation of the Roche MagNA Pure 96 nucleic acid extraction platform for the Seegene Anyplex II HPV28 detection assay.Semantic proximity Read ↗

The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.Semantic proximity Read ↗

A rapid DNA extraction method suitable for human papillomavirus detection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.